SCHEMBL18212430

SCHEMBL18212430

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)cc4)n3)cc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.67
▸ MEN1 O00255 5/20 0.60
▸ KMT2A Q03164 5/20 0.60
▸ ALDH1A1 P00352 4/20 0.60
▸ MAPT P10636 2/20 0.60
▸ HPGD P15428 2/20 0.60
▸ ADORA2A P29274 2/20 0.59
▸ ADORA1 P30542 2/20 0.59
▸ POLB P06746 1/20 0.59
▸ ADORA3 P0DMS8 1/20 0.59
▸ ADORA2B P29275 1/20 0.59
▸ NPC1 O15118 3/20 0.58
▸ RAB9A P51151 3/20 0.58
▸ MAPK1 P28482 2/20 0.58
▸ CYP3A4 P08684 1/20 0.55
▸ TAAR1 Q96RJ0 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ TDP1 Q9NUW8 1/20 0.55
▸ NFKB1 P19838 2/20 0.55
▸ NFKB2 Q00653 2/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19543731 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL15894213 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13492073 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL13492067 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL12636103 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL23608941 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL2876356 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18212400 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL18270369 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT
SCHEMBL338622 1.00 L3MBTL1 (0.67) L3MBTL1MEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11744151-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-29 — — US disclosed
US-11744151-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-29 — — US disclosed
US-10403826-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2019-09-03 — — US disclosed
US-20160329502-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-11-10 — — US disclosed
US-20160329502-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2016-11-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10403826-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, JUND L3MBTL1 2912/4885MEN1 4702/4885KMT2A 2776/4885
US-11744151-B2 Organic electroluminescent materials and devices OCIAD2, OCIAD1, JUND L3MBTL1 2912/4885MEN1 4702/4885KMT2A 2776/4885
US-20160329502-A1 Organic Electroluminescent Materials and Devices OCIAD2, OCIAD1, JUND L3MBTL1 2912/4885MEN1 4702/4885KMT2A 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback